Abstract
In this present investigation pharmacologically active compounds were isolated from red algae (Asparagopsis taxiformis) and their efficacy was evaluated against theLeptospira javanica isolates of rodent carriers. The GC-MS analysis of the purified compound revealed the presence of 4,5-dimethyl-1H-pyrrole-2-carboxylic acid ethyl ester (56.012%), fattyacids, 14-methyl-pentadecanoic acid methyl ester (26.6%), octadecanoic acid methyl ester (8.46%), octadec-9-enoic acid 2,3-dihydroxy-propyl ester (4.11%), 9-octadecanoic acid, methyl ester (4.535%) and trace amount of chlorobenzene (0.09%). MICs and MBCs of the purified compound against pathogenic leptospiral strains belonging to 14 serovars and 11 isolates belonging to serovarjavanica ofLeptospira borgpetersenii were determined in a range of 100–1600 μg/ml. The antibiotics penicillin and doxycycline were used as the standards for the efficiency determination of the seaweed extract against the leptospiral reference serovars and isolates. The minimal inhibitory concentration of penicillin and doxycyline were in the range of 25–200 μg/ml. The seaweed active fraction exhibited comparable MIC and MBC values with that of the standard antibiotic doxycycline. In the present study the seaweed compound has been developed to apply for the 2nd nodal point of transmission cycle, the environment. Thus the present study draws the development of a novel drug to treat leptospires particularly in environments augmented with rodent carriers.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Broughton E.S., Flack L.E. (1986). The susceptibility of a strain ofLeptospira interrogans serogroup Icterohaemorrhagiae to amoxycycillin, erythromycin, lincomycin, tetracycline, oxytertracycline and minocycline. Zentbl. Bakteriol. Mikrobiol. Hyg. Ser. A., 261:425–431.
Edwards C.N., Nicholson G.D., Hassell T.A., Everard C.O.R., Callender J. (1988). Penicillin therapy in icteric leptospirosis. Am. J. Trop. Med. Hyg., 39: 388–390.
Faine S.B., Adler B., Bolin C., Perolat P. (1999).Leptospira and leptospirosis. 2nd edn., MediSci, Melbourne, Australia.
Fenical W., Paul V.S. (1984). Antimicrobial and cytotoxic terpenoids from tropical green algae of the familyUdoteaceae. In: Bird C.J., Ragan M.A., Eds, 11th International Seaweed Symposium. Dr. W. Junk Publishers, Dordrccht, Boston, Lancaster, pp. 135–140.
Glombitza K.W. (1979). Antibiotics from algae. In: Hoppe I.L.A., Ed., Marine Algae in Pharmaceutical Science, Waiter de Gruyter, Berlin, New York, p. 303.
Harder R. (1917). Ernahrungphysiologische untersuchughen an Cyanophyceen, Hauptsac hlich an endophytischenNostoc punctiforme. Z. Bot., 9: 145.
Hospenthal D.R., Murray C.K. (2004). Broth microdilution susceptibility testing forLeptospira spp. Antimicrob Agents and Chemother., 48: 1548–1552.
Kmety E., Dikken H. (1993). Classification of the speciesLeptospira interrogans and history of its serovars. University Press, Groningen, The Netherlands.
McClain B.L., Ballou W.R., Harrison S.M., Steinweg D.L. (1984). Doxycycline therapy for leptospirosis. Ann. Intern. Med., 100: 696–698.
Michanek G. (1979). Seaweed resources for pharmaceutical uses. In: Hoppe I.L.A., Ed., Marine Algae in Pharmaceutical Science, Waiter de Gruyter, Berlin, New York, pp. 203–235.
Murgia R., Cinco M. (2001). Sensitivity ofBorrelia andLeptospira to quimupristin-dallforpristin (Synercid)in vitro. New Microbiol., 24: 193–196.
Natarajaseenivaasan K., Ratnam S. (1997). Expermental leptospirosis in laboratory mice and rats. J. Commun. Dis., 29: 291–293.
Paul V.J., Puglisi M.P. (2004). Chemical mediation of interactions among marine organisms. Nat. Prod. Rep., 21: 189–209.
Prescott J. (1991). Treatment of leptospirosis. Cornell Vet., 81: 7–12.
Sehgal S.C., Sugunan A.P., Murhekar M.V., Sharma S., Vijayachari P. (2000). Randomised controlled trial of doxycycline prophylaxis in an endemic area. Int. J. Antimicrob. Agents, 13: 249–255.
Shanmughapriya S., Manilal A., Sujith S., Selvin J., Seghal Kiran G., Natarajaseenivasan K. (2008). Antimicrobial activity of seaweeds extracts against multiresistant pathogens. Ann. Microbiol., 58: 535–541.
Smith P., Hiney M.P., Samuselsen O.B. (1994). Bacterial resistance to antimicrobial agents used in fish farming. Annu. Rev. Fish Dis., 4: 273–313.
Vijayachari P., Sugunan A.P., Sharma S., Roy S., Natarajaseenivasan K., Sehgal S.C. (2008). Leptospirosis in the Andaman Islands, India. Trans. R. Soc. Trop. Med. Hyg., 102: 117–122.
Vijayachari P., Hartskeerl R.A., Sharma S., Natarajaseenivasan K., Roy S., Terpstra W.J., Sehgal S.C. (2004). A unique strain ofLeptospira isolated from a patient with pulmonary haemorrhages in Andaman islands: a proposal of serovar Portblairi of serogroup Sehgali. Epidemiol. Infect., 132: 663–673.
Watt G., Padre L.P., Tuazon M.L., Calubaquib C.J., Santiago E., Ranoa C.P., Laughlin L.W. (1988). Placebo-controlled trial of intravenous penicillin for severe and late leptospirosis. Lancet, 1: 433–435.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vedhagiri, K., Manilal, A., Valliyammai, T. et al. Antimicrobial potential of a marine seaweedAsparagopsis taxiformis againstLeptospira javanica isolates of rodent reservoirs. Ann. Microbiol. 59, 431–437 (2009). https://doi.org/10.1007/BF03175127
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03175127